Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
Advanced Micro Devices
AMD
|
+$296M |
| 3 |
Apple
AAPL
|
+$275M |
| 4 |
Qualcomm
QCOM
|
+$218M |
| 5 |
NVIDIA
NVDA
|
+$187M |
Top Sells
| 1 |
Amazon
AMZN
|
+$536M |
| 2 |
Uber
UBER
|
+$438M |
| 3 |
Chevron
CVX
|
+$280M |
| 4 |
Meta Platforms (Facebook)
META
|
+$264M |
| 5 |
CrowdStrike
CRWD
|
+$242M |
Sector Composition
| 1 | Technology | 19.65% |
| 2 | Healthcare | 18.08% |
| 3 | Consumer Discretionary | 13.75% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Rush Enterprises Class A
RUSHA
$4.49B
| $10.3M | 0.02% |
246,149
-41,165
| -14% | -$1.72M |
|
902
Healthcare Realty
HR
$6.43B
| $10.3M | 0.02% |
+625,272
| New | +$10.3M |
|
903
Comfort Systems
FIX
$27B
| $10.3M | 0.02% |
33,800
+11,800
| +54% | +$3.59M |
|
904
Potbelly
PBPB
$515M
| $10.3M | 0.02% |
1,278,854
-105,594
| -8% | -$848K |
|
905
The RMR Group
RMR
$286M
| $10.3M | 0.02% |
454,217
+1,303
| +0.3% | +$29.4K |
|
906
Immunovant
IMVT
$2.86B
| $10.2M | 0.02% |
388,100
+48,400
| +14% | +$1.28M |
|
907
Invesco
IVZ
$10.1B
| $10.2M | 0.02% |
682,200
-214,900
| -24% | -$3.21M |
|
908
Moderna
MRNA
$9.78B
| $10.2M | 0.02% |
85,900
-21,900
| -20% | -$2.6M |
|
909
Bandwidth Inc
BAND
$463M
| $10.2M | 0.02% |
604,200
+51,542
| +9% | +$870K |
|
|
NWLI
910
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $10.2M | 0.02% |
20,500
+4,318
| +27% | +$2.15M |
|
911
Dole
DOLE
$1.29B
| $10.2M | 0.02% |
830,900
+88,900
| +12% | +$1.09M |
|
|
FFNW
912
DELISTED
First Financial Northwest, Inc
FFNW
| $10.2M | 0.02% |
481,101
-1,000
| -0.2% | -$21.1K |
|
913
Check Point Software Technologies
CHKP
$21.1B
| $10.2M | 0.02% |
61,608
-105,700
| -63% | -$17.4M |
|
914
Matador Resources
MTDR
$6.04B
| $10.2M | 0.02% |
+170,506
| New | +$10.2M |
|
|
UHT
915
Universal Health Realty Income Trust
UHT
$572M
| $10.1M | 0.02% |
258,810
-2,200
| -0.8% | -$86.1K |
|
916
RCM Technologies
RCMT
$196M
| $10.1M | 0.02% |
539,373
-15,400
| -3% | -$288K |
|
917
Columbia Financial
CLBK
$1.61B
| $10.1M | 0.02% |
674,332
-15,900
| -2% | -$238K |
|
918
Boston Properties
BXP
$12B
| $10.1M | 0.02% |
163,900
+110,700
| +208% | +$6.81M |
|
919
Axon Enterprise
AXON
$59.8B
| $10.1M | 0.02% |
34,252
-5,306
| -13% | -$1.56M |
|
920
Idexx Laboratories
IDXX
$51.6B
| $10M | 0.02% |
20,604
-13,200
| -39% | -$6.43M |
|
921
Omega Healthcare
OHI
$12.6B
| $10M | 0.02% |
293,078
+24,400
| +9% | +$836K |
|
922
Dimensional Short-Duration Fixed Income ETF
DFSD
$5.19B
| $10M | 0.02% |
213,517
+78,838
| +59% | +$3.71M |
|
923
ATI
ATI
$10.5B
| $9.99M | 0.02% |
180,192
+44,600
| +33% | +$2.47M |
|
924
Tapestry
TPR
$22.2B
| $9.99M | 0.02% |
233,500
-239,500
| -51% | -$10.2M |
|
925
ANI Pharmaceuticals
ANIP
$2.11B
| $9.99M | 0.02% |
156,802
+20,900
| +15% | +$1.33M |
|